Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

107 recalls · Class III, newest first

Class III · Low risk

Gatifloxacin Ophthalmic Solution

Failed Stability Specifications: Out-of-specification results observed in a water loss test that might affect the assay content and alter drug concentration.

Terminated Stability / shelf life Lupin Pharmaceuticals Inc. NDC 68180-435-01 D-0326-2022
Class III · Low risk

CTx36 Kit

Subpotent Drug: Product contains less Sodium Fluoride than listed on product label.

Terminated Wrong potency / content Dental Alliance Holdings LLC D-0457-2022
Class III · Low risk

CTx26 Kit

Subpotent Drug: Product contains less Sodium Fluoride than listed on product label.

Terminated Wrong potency / content Dental Alliance Holdings LLC D-0456-2022
Class III · Low risk

CTx21 Kit

Subpotent Drug: Product contains less Sodium Fluoride than listed on product label.

Terminated Wrong potency / content Dental Alliance Holdings LLC D-0455-2022
Class III · Low risk

CTx7 Kit

Subpotent Drug: Product contains less Sodium Fluoride than listed on product label.

Terminated Wrong potency / content Dental Alliance Holdings LLC D-0454-2022
Class III · Low risk

Tydemy

Subpotent Drug

Terminated Wrong potency / content Lupin Pharmaceuticals Inc. NDC 68180-904-11 D-0264-2022
Class III · Low risk

Fexofenadine HCl

Failed dissolution specifications

Terminated Dissolution failure Dr. Reddy's Laboratories, Inc. NDC 43598-823-31 D-0275-2022

Recalls by year